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Abstract 
Wilms’ tumour (nephroblastoma) is the most common renal tumour in children. Wilms’ 
tumour in adults is extremely rare and has a poorer prognosis than paediatric Wilms’ 
tumour. It is difficult to differentiate adult Wilms’ tumour from renal cell carcinoma based 
on radiological findings alone. The diagnosis in adults is often serendipitous following 
nephrectomy for presumed renal cell carcinoma. Because of the paucity of literature, there 
are no standard protocols for the management of adult Wilms’ tumour, and therefore, it is 
managed as per paediatric Wilms’ tumour. Herein, we report the case of adult Wilms’ 
tumour in a 43-year-old man, which was diagnosed unexpectedly following nephrectomy for 
presumed renal cell carcinoma. 
Keywords: adult Wilms’ tumour; nephroblastoma; renal tumour 
Received: 21 February 2016; Accepted after revision: 20 April 2016; Published: 23 May 2016. 
Author for correspondence: Sunny Modi, MBBS, Urology Department, Greenslopes Private Hospital, Brisbane, 
Australia. Email: sunny_modi003@hotmail.com 
How to cite: Modi S, Tiang KW, Inglis P, Collins S. Sequential therapy in metastatic renal cell carcinoma. J Kidney 
Cancer VHL 2016;3(2):1–7. Doi: http://dx.doi.org/10.15586/jkcvhl.2016.52 
Copyright: The Authors. 
License: This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). 
http://creativecommons.org/licenses/by/4.0 
Introduction 
Wilms’ tumour, named after the 19th 
century German surgeon Carl Max Wilhelm 
Wilms, is probably derived from primitive 
metanephric blastema (1). Wilms’ tumour, 
also known as nephroblastoma, is the most 
common paediatric cancer of the kidney, 
occurring mainly in the first 5years of life 
with peak incidence between 3 and 4 years 
of age (2). Wilms’ tumour is very rare in 
adults with an incidence of about 0.2 per 
million per year (3) and represents less 
than 1% of all diagnosed renal tumours (4). 
There are approximately 300 documented 
cases of adult Wilms’ tumour in the 
literature to date (5). Symptomatology of 
adult Wilms’ tumour differs significantly 
compared with that of children’s. Adults 
normally present with abdominal pain and 
haematuria while in children, the tumour 
is frequently a painless, rapidly enlarging 
abdominal mass that is often readily 
palpable. Because of its anatomical 
position, venous drainage and lymphatic 
drainage, it is not uncommon for distant 
 
Modi et al. MTSCC Kidney with Sarcomatoid Dedifferentiation 
 
Journal of Kidney Cancer and VHL 2016; 3(2):1-7.                http://jkcvhl.com 2 
 
metastasis to the lungs and liver. 
Metastasis to the bone, skin, bladder, large 
intestine, central nervous system and the 
contralateral kidney is rare (3). 
There is no significant histological and 
radiological difference between adult and 
childhood Wilms’ tumour (2). In fact, they 
share the classical triphasic 
histopathological features such as 
blastemal, epithelial and stromal features 
under the microscope. The histological 
appearance is characterized by marked 
structural diversity, and the occurrence of 
all three types in the same case is 
uncommon (1). Adult Wilms’ tumour is 
diagnosed based on well-known criteria 
described by Kilton et al. (6). They include 
the following: 1, the tumour under 
consideration should be a primary renal 
neoplasm; 2, presence of primitive 
blastemic spindle or round cell 
component; 3, formation of abortive or 
embryonal tubules or glomerular 
structures; 4, no area of tumour 
diagnostic of renal cell carcinoma; 5, 
pictorial confirmation of histology and 6, 
patient’s age should be >15 years. In 
1980, Kilton et al. (6) reported 35 cases of 
adult Wilms’ tumour complying with all 
the above criteria. 
Clinical outcome for adults is inferior when 
compared with children, although better 
results are reported when treated within 
paediatric trials (7). Multiple factors 
including the unfamiliarity of oncologists 
and pathologists with adult Wilms’ tumour, 
lack of standardized treatment, and 
consequent delays in initiating the 
appropriate risk-adapted therapy may 
contribute to the poor outcome. Because of 
the fact that nephroblastoma is a very rare 
type of cancer, adult patients are treated 
based on the available treatment protocols 
used for children, which was developed by 
the National Wilms’ Tumour Study Group 
(NWTS) in North America, and the 
International Society of Pediatric Oncology 
(SIOP) (8). 
Case report 
A 43-year-old Caucasian man, with a 4-
week history of right upper quadrant and 
right flank pain radiating to his right 
testicle, presented to his general 
practitioner. There was no preceding 
trauma, haematuria or any other systemic 
symptoms. The past medical history 
included osteoid osteoma in the left upper 
femur, which was removed in 2007. He also 
had L4/5 microdiscectomy. There was no 
positive family history of medical problems 
or cancer. He was a non-smoker, had no 
allergies and was not taking any regular 
medications. The general practitioner 
organized an ultrasound, which revealed a 
large subcapsular haematoma measuring 7 
× 5 × 7 cm in the right kidney compressing 
the renal cortex. Further investigation with 
computed tomography (CT) scan of the 
abdomen with intravenous contrast revealed 
enlarged right kidney with subcapsular 
haematoma and a mass lesion within the 
right lower pole measuring up to 7.4 × 7.5 × 
9.2 cm with associated paracaval 
lymphadenopathy producing compression of 
the right renal vein and inferior vena cava 
(Figures 1 and 2). The patient was then 
referred to an urologist for further 
management. 
Physical examination revealed that the 
right kidney area was filled, with minimal 
tenderness. The haemoglobin 
concentration was 140 g/L. There was a 
mild elevation of creatinine (116 μmol/L), 
and the estimated glomerular filtration rate 
was 66 ml/min. CT staging showed a large 
right renal tumour and significant 
paracaval lymphadenopathy producing 
compression of the right renal vein and 
inferior vena cava. The size of the tumour 
was substantially increased in size to 11.5 
× 11.6 × 11.5 cm when compared with that 
in the previous CT scan. 
A preliminary diagnosis of renal cell 
carcinoma was made based on the clinical 
findings and investigations. The patient 
underwent open radical right nephrectomy, 
retroperitoneal lymph node dissection and 
partial excision, and reconstruction of vena 
cava. The renal samples were sent for 
histopathology. The right kidney specimen 
(with fibro adipose tissue) weighed 1291 g 
and 175 × 140 × 110 mm in size. The 
tumour was located in the mid-pole and 
lower pole of approximately 100 × 95 × 100 
mm. On gross inspection, the tumour was 
cream and pink in colour with mixture of 
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Figure 1. CT scan – coronal view. Large mass lesion (arrow) within right kidney measuring up to 7.4 × 
7.5 × 9.2 cm. 
Figure 2. CT scan – coronal view showing right kidney mass with subcapsular haematoma (arrows). 
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solid and cystic components (Figure 3). 
There was an extensive haematoma within 
the lumen of the cyst and possible necrosis. 
The retrocaval lymph node measured 4 cm. 
Histologically, the tumour comprised of 
blastemal, stromal and anaplastic elements. 
The blastemal elements were present in 
nodular fashion and had syncytial pattern 
with no diffuse infiltrative component 
(Figure 4). The anaplastic elements were 
focally present in stromal elements (nuclear 
sized 3× tumour cells and tripolar mitosis; 
Figure 5). The stromal elements were 
present with focal anaplastic elements. There 
were features of necrosis, haemorrhage and 
cystic degeneration. The morphologic and 
histopathology features favoured adult 
Wilms’ tumour with synovial sarcoma as a 
differential diagnosis. A fluorescence in situ 
hybridization analysis showed loss of 
heterogeneity (LOH) for 1p 16q, which is 
associated with poor outcomes in paediatric 
Wilms’ tumour. The pathological staging was 
pT3a, pN1 and cM0 (pT3a – tumour invading 
renal sinus fat but not beyond Gerota’s 
fascia, pN1 – metastasis in single regional 
lymph node, cM0 – not stated). The patient 
was subsequently treated with adjuvant 
combination chemotherapy and 
radiotherapy. 
Based on the age of presentation, 
unfavourable histology and chromosomal 
LOH for 1p16q, the tumour was considered 
high-risk, and chemotherapy was initiated as 
per the Children’s Oncology Group UH-1 
protocol, including early radiation to the 
tumour bed, and multiagent chemotherapy 
including actinomycin D, vincristine and 
doxorubicin. Radiation and chemotherapy 
were commenced concurrently within 3 
weeks of surgery. The intensity of 
chemotherapy was maintained as per 
protocol with granulocyte support. The 
patient has been followed up at regular 
intervals with CT scans and routine blood 
tests. There has been no radiological or 
clinical recurrence at the end of 12 months of 
initial diagnosis. 
Discussion 
Wilms’ tumour is the most common renal 
tumour accounting for 85% of paediatric 
renal neoplasms. The tumour is most 
prevalent in the first 5 years of life with  
Figure 3. Right kidney specimen – cream and pink colour tumour with mixture of solid and cystic 
components with haematoma in the lumen of the cyst and possible necrosis. 
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Figure 4. Microscopic features of adult Wilms’ tumour showing blastemal elements.
peak incidence between 3 and 4 years of 
age (2). The annual incidence rate in 
children under 15 years is 7 to 10 cases 
per million, accounting for 6–7% of all 
paediatric malignant tumours (9). The 
spontaneous rupture and haemorrhage as 
Figure 5. Microscopic features of adult Wilms’ tumour showing stromal elements and focal anaplastic 
elements. 
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presenting signs of adult Wilms’ tumour also 
are very rare (8). It is difficult to diagnose 
adult Wilms’ tumour preoperatively because 
there are no specific radiographic findings (6). 
Treatment of Wilms’ tumour invariably is 
multimodal involving surgery, 
chemotherapy and/or radiotherapy. Two 
accepted management protocols are the 
NWTS and SIOP. NWTS has always 
recommended upfront nephrectomy to 
define the accurate stage of the tumour and 
the histology, on which further treatment 
stratification is decided. In contrast, the 
SIOP investigators pioneered the concept of 
prenephrectomy chemotherapy in all 
patients over 6 months of age to reduce the 
tumour size and prevent intraoperative 
tumour rupture causing spillage and to 
increase the proportion of children with a 
lower tumour stage that required less 
overall treatment (10). 
The NWTS group has reported an overall 
survival rate of 82% in adults with 
favourable histology Wilms’ tumour (11). 
Terenziani et al. (5) reported their 
institutional experience regarding adult 
Wilms’ tumour wherein 17 patients with 
adult Wilms’ tumour who were older than 
16 years were treated according to 
paediatric Wilms’ tumour guidelines. In 
this series, the overall survival was 62.4% 
at 5 years. Reinhard et al. (12) reported 
their experience with 30 cases of adult 
Wilms’ tumour. A complete remission was 
achieved in 24 patients. Event-free survival 
was 57%, and the overall survival was 
83%. They concluded that adults can be 
cured in a high percentage by a multimodal 
treatment according to paediatric 
protocols. 
It is well documented that Wilms’ tumours 
are radio- and chemo-sensitive, and delay 
in treatment can adversely affect outcomes 
(4). There are a number of case series that 
suggest that the outcome for adult Wilms’ 
tumour has improved when paediatric 
treatment approaches, including 
multimodality chemo- and radiotherapy 
adapted from the paediatric treatment 
protocols, are used (4, 11–13). Long-term 
follow-up of patients not only concerns the 
risk of relapse but the cardiotoxicity, 
neurotoxicity, hepatotoxicity and 
nephrotoxicity of the chemotherapeutics. 
Conclusion 
Adult Wilms’ tumour is a rare entity with 
mainly case reports-only literature. There 
are no established protocols for treatment 
of this group of patients. Being so rare, the 
diagnosis is generally made on 
postoperative pathology. Treatment of this 
tumour is multimodal incorporating 
surgery and lengthy chemotherapy, which 
needs to be tailored to the patient. Its 
prognosis is poorer than that of Wilms’ 
tumour in the paediatric population. 
Relapse in the first year after treatment is a 
predictor of poor outcome. It is recognized 
that Wilms’ tumour in adults is a rare 
entity, and the importance of registering 
such patients to international data bases 
will assist in the research and development 
of future management guidelines for this 
tumour. 
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